Article citationsMore>>

Tobaiqy, M., Maclure, K., Elkout, H. and Stewart, D. (2021) Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database. Vaccines, 9, Article 1326.
https://doi.org/10.3390/vaccines9111326

has been cited by the following article:

• TITLE: Arterial and Venous Thrombosis following Vaccination against COVID-19 with Astra-Zeneca Vaccine Revealing Thrombophilia

  AUTHORS: Bah Mamadou Bassirou, Doumbouya Amadou Dioulde, Balde Mamadou Aliou, Balde Thierno Hamidou, Sylla Ibrahima Sory, Balde Elhadj Yaya, Kone Alpha, Barry Ibrahima Sory, Samoura Sana, Beavogui Mariam, Diakité Souleymane, Balde Mamadou Dadhi

  KEYWORDS: Thrombophilia, Thrombosis, Vaccine, AstraZeneca

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.13 No.4, April 17, 2023

  ABSTRACT: Vaccination against COVID-19 is the most recognised means of containingthe pandemic. Vaccines are not without side effects, particularly vascularthrombosis. But before blaming the vaccines, a thorough assessment of thrombotic risk factors is necessary. We report a case of arterial and venous thrombosis after vaccination with AstraZeneca revealing an exaggeration of factor VIII in a 37-year-old female patient. The angioscanner showed a venous thrombosis of the right subclavian, a pulmonary embolism and the presence of a thrombus in the aorta. The biology was in favour of a high level of factor VIII. The patient was treated with an antivitamin K,andthe clinical evolution was favourable.